Product
Recombinant interferon alfa-2b
1 clinical trial
1 indication
Indication
MelanomaClinical trial
Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk MelanomaStatus: Active (not recruiting), Estimated PCD: 2015-06-01